Menu

Close

Profiling the surface proteome identifies actionable biology for TSC1 mutant cells beyond mTORC1 signaling

Junnian Wei, Kevin K. Leung, Charles Truillet, Davide Ruggero, James A. Wells, Michael J. Evans

Preprint posted on August 01, 2018 https://www.biorxiv.org/content/early/2018/08/01/382929

Cell surface proteomics reveals new mTORC1-independent functions of TSC1 and suggests new avenues to develop therapies for TSC1-mutant tumours.

Selected by Rob Hynds

Background

Tuberous sclerosis is an incurable autosomal dominant disorder characterised by skin lesions and the formation of benign tumours in multiple organs, particularly the central nervous system. The disease is caused by mutations in the tumour suppressor genes TSC1 (tuberous sclerosis 1) and TSC2, which function in the PI3K/mTOR signalling cascade and are also mutated in some cancers.

Class 1 PI3K activation recruits Akt to cell membranes via PIP3, where it is phosphorylated by mTORC2 and PDK1. Activated Akt phosphorylates TSC2, which exists in complex with TSC1. In this state, the GTPase-activating protein (GAP) function of TSC2 is inhibited, leading to the accumulation of active, GTP-bound Rheb and mTORC1 activation via downstream mediators such as p70S6K and 4E-BP1. As such, mutations in TSC1/TSC2 lead to hyperactivation of mTORC1.

Everolimus, an mTORC1 inhibitor, is approved for the control of tuberous sclerosis but TSC1/TSC2 mutant cancers are frequently not susceptible to mTORC1 inhibition, suggesting that TSC1/TSC2 mutations might have pro-tumorigenic effects that are mTORC1-independent.

Schematic representation of the role of the TSC complex in mTORC1 signalling.

Key findings

In their preprint, Wei, Leung and their colleagues report a liquid chromatography-mass spectrometry experiment comparing Tsc1-/-mouse embryonic fibroblasts (MEFs) with isogenic Tsc1+/+cells. After stable isotope labelling with amino acids in culture, N-linked glycosylation enrichment allowed interrogation of the cell surface proteome. 20 proteins were identified as upregulated in Tsc1-/-MEFs; reassuringly, these included proteins whose expression is known to be upregulated by mTORC1 activation and multiple proteins involved in cell adhesion, which TSC1 is known to regulate.

After flow cytometry validation, the top two hits were neprilysin (NEP) and aminopeptidase N (APN/CD13). TSC1 knockdown by shRNA or deletion using CRISPR-Cas9 led to increased NEP and APN expression in human cancer cell lines. Moreover, suppression of NEP and APN using siRNA led to large reductions in cell line proliferation. Existing inhibitors of these proteins had mixed results: LBQ657, a NEP inhibitor, and bestatin, an APN inhibitor, had no impact on proliferation but a more specific APN inhibitor, CHR2797, was effective through the induction of apoptosis. Counterintuitively, CHR2797 did not affect mTORC1 substrate phosphorylation and APN expression was not reduced by CHR2797 in TSC1-null cell lines, suggesting that TSC1 loss upregulates APN independently of mTORC1 signalling. Combinations of mTORC1 inhibitors and CHR2797 were synergistic, suggesting a novel therapeutic strategy for TSC1-mutant disease.

Conclusions and Outlook

Since Tsc1-/- MEFs do not have higher expression of APN and APN upregulation is independent of mTORC1, these data suggest that TSC1 mutations have effects that are independent of mTORC1. As such, the current strategy to treat TSC-mutant tumours with mTORC1 inhibitors may be insufficient and these might be susceptible to combination therapies. It’s interesting too that TSC2-deficient tumours can respond to checkpoint inhibition so we will have the opportunity to decipher the best combination of inhibitors of mTORC1, inhibitors of these novel targets and immunotherapies over the coming years.

The preprint suggests new avenues for basic research as many of the 20 proteins found to be upregulated are poorly understood. It also adds to recent progress on the mTORC1-independent roles of the TSC1/TSC2 complex: both TSC1 and TBC1D7, a third subunit of the TSC1/TSC2 complex that binds to and stabilises TSC1 but is not expressed in all tissues, are tumour suppressors in canonical mTORC1 signalling. However, disruption of their interaction seems to be growth promoting in lung cancer cell lines, supportive of the idea that these proteins participate in other pathways independently of TSC2. To date, TSC1 has been shown to participate in TGFbeta-induced Smad2/3 signalling (and consequently affect the Hedgehog pathway) and TBC1D7 operates independently in insulin signalling. As such, the elucidation of the mechanism by which APN and NEP are upregulated in TSC1-/- cells will be noteworthy.

Further reading

Rosset, C., Netto, C.B.O. and Ashton-Prolla, P. TSC1 and TSC2 gene mutations and their implications for treatment in Tuberous Sclerosis Complex: a review. Genetics and Molecular Biology, 2017. 40(1): p. 69–79.

Questions for Authors

  1. The authors performed their discovery experiment in MEFs. How significant might species differences be? Might there be additional targetable surface proteins in TSC1-mutant human cells?
  2. AGRL2 is mentioned as an upregulated gene that has low expression in normal tissues – could this (or other hits) be a target for CAR T cell therapy in TSC1-mutant disease, independently of the success of small molecule inhibitor-based approaches?

Tags: cancer, mass spectrometry, proteomics, tuberous sclerosis

Posted on: 9th August 2018

Read preprint (No Ratings Yet)




  • Author's Response

    Junnian Wei, Jim Wells and Mike Evans shared

    Thanks for taking the time to highlight our work.

    Q1. This is an important point.  We chose to study MEFs as complete TSC1 knockout cells already existed, and were previously studied to glean important insights about the biology associated with TSC1/2 loss and mTORC1 signaling. While APN and NEP are both upregulated in human cell lines due to TSC1 loss, it is possible that there are human-specific targets associated with TSC1 that our proteomics screen did not capture. We are planning proteomics experiments in human bladder cancer cell lines isogenic with respect to TSC1 expression to address this question.

    Q2. Certainly this is a possibility, assuming potent and selective monoclonal antibodies can be raised to an extracellular epitope.  AGRL2 is also a GPCR, so small molecule agonists or antagonists could also have bioactivity.  We are conducting further studies to understand the role of AGRL2 expression and/or activity to the survival of cells with TSC1 mutations.

    Have your say

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Sign up to customise the site to your preferences and to receive alerts

    Register here

    Also in the cancer biology category:

    Quantification of microenvironmental metabolites in murine cancer models reveals determinants of tumor nutrient availability

    Mark R Sullivan, Laura V Danai, Caroline A Lewis, et al.



    Selected by Maria Rafaeva

    Mechanical Stretch Kills Transformed Cancer Cells

    Ajay Tijore, Mingxi Yao, Yu-Hsiu Wang, et al.



    Selected by Joseph Jose Thottacherry

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    A conserved MFS orchestrates a subset of O-glycosylation to facilitate macrophage dissemination and tissue invasion

    Katarina Valoskova, Julia Biebl, Marko Roblek, et al.



    Selected by Giuliana Clemente

    1

    MRE11-RAD50-NBS1 activates Fanconi Anemia R-loop suppression at transcription-replication conflicts

    Emily Yun-Chia Chang, James P Wells, Shu-Huei Tsai, et al.



    Selected by Katie Weiner

    1

    Applications, Promises, and Pitfalls of Deep Learning for Fluorescence Image Reconstruction

    Chinmay Belthangady , Loic A. Royer



    Selected by Romain F. Laine

    Basal extrusion drives cell invasion and mechanical stripping of E-cadherin

    John Fadul, Gloria M Slattum, Nadja M Redd, et al.



    Selected by William Hill

    Molecularly distinct models of zebrafish Myc-induced B cell leukemia

    Chiara Borga, Clay Foster, Sowmya Iyer, et al.



    Selected by Hannah Brunsdon

    1

    The landscape of antigen-specific T cells in human cancers

    Bo Li, Longchao Liu, Jian Zhang, et al.



    Selected by Rob Hynds

    1

    Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma.

    Andrea Palamidessi, Chiara Malinverno, Emanuela FRITTOLI, et al.



    Selected by Tim Fessenden

    1

    STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pigmentation pathway

    Alexander Swoboda, Robert Soukup, Katharina Kinslechner, et al.



    Selected by Hannah Brunsdon

    Memory sequencing reveals heritable single cell gene expression programs associated with distinct cellular behaviors

    Sydney M Shaffer, Benjamin L Emert, Ann E. Sizemore, et al.



    Selected by Leighton Daigh

    2

    Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling

    Amber N Stratman, Olivia M Farrelly, Constantinos M Mikelis, et al.



    Selected by Coert Margadant

    Precise tuning of gene expression output levels in mammalian cells

    Yale S. Michaels, Mike B Barnkob, Hector Barbosa, et al.



    Selected by Tim Fessenden

    1

    Moving beyond P values: Everyday data analysis with estimation plots

    Joses Ho, Tayfun Tumkaya, Sameer Aryal, et al.



    Selected by Gautam Dey

    1

    JNK-mediated spindle reorientation in stem cells promotes dysplasia in the aging intestine

    Daniel Hu, Heinrich Jasper



    Selected by Maiko Kitaoka

    Also in the cell biology category:

    Synthetic pluripotent bacterial stem cells

    Sara Molinari, David L. Shis, James Chappell, et al.



    Selected by Lorenzo Lafranchi

    A DNA-based voltmeter for organelles

    Anand Saminathan, John Devany, Kavya S Pillai, et al.



    Selected by Robert Mahen

    Central spindle microtubules are strongly coupled to chromosomes during both anaphase A and anaphase B

    Che-Hang Yu, Stefanie Redemann, Hai-Yin Wu, et al.



    Selected by Federico Pelisch

    1

    Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division

    Evgeny Zatulovskiy, Daniel F. Berenson, Benjamin R. Topacio, et al.



    Selected by Zaki Ahmad

    1

    Minimal membrane interactions conferred by Rheb C-terminal farnesylation are essential for mTORC1 activation

    Shawn M Ferguson, Brittany Angarola



    Selected by Sandra Malmgren Hill

    Mechanical Stretch Kills Transformed Cancer Cells

    Ajay Tijore, Mingxi Yao, Yu-Hsiu Wang, et al.



    Selected by Vibha SINGH

    EHD2-mediated restriction of caveolar dynamics regulates cellular lipid uptake

    Claudia Matthaeus, Ines Lahmann, Severine Kunz, et al.



    Selected by Andreas Müller

    1

    Mechanical Stretch Kills Transformed Cancer Cells

    Ajay Tijore, Mingxi Yao, Yu-Hsiu Wang, et al.



    Selected by Joseph Jose Thottacherry

    Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells

    Jayashree Chadchankar, Victoria Korboukh, Peter Doig, et al.



    Selected by Mila Basic

    A metabolic switch from OXPHOS to glycolysis is essential for cardiomyocyte proliferation in the regenerating heart

    Hessel Honkoop, Dennis de Bakker, Alla Aharonov, et al.



    Selected by Andreas van Impel

    1

    S-acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate desmosome assembly and cell adhesion.

    Keith T Woodley, Mark O Collins



    Selected by Abagael Lasseigne

    3

    A complex containing lysine-acetylated actin inhibits the formin INF2

    Mu A, Tak Shun Fung, Arminja N. Kettenbach, et al.



    Selected by Laura McCormick

    1

    Super-resolution Molecular Map of Basal Foot Reveals Novel Cilium in Airway Multiciliated Cells

    Quynh Nguyen, Zhen Liu, Rashmi Nanjundappa, et al.



    Selected by Robert Mahen

    Single cell RNA-Seq reveals distinct stem cell populations that drive sensory hair cell regeneration in response to loss of Fgf and Notch signaling

    Mark E. Lush, Daniel C. Diaz, Nina Koenecke, et al.

    AND

    Distinct progenitor populations mediate regeneration in the zebrafish lateral line.

    Eric D Thomas, David Raible



    Selected by Rudra Nayan Das

    1

    Actomyosin-II facilitates long-range retrograde transport of large cargoes by controlling axonal radial contractility

    Tong Wang, Wei Li, Sally Martin, et al.



    Selected by Ivana Viktorinová

    Atlas of Subcellular RNA Localization Revealed by APEX-seq

    Furqan M Fazal, Shuo Han, Pornchai Kaewsapsak, et al.

    AND

    Proximity RNA labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules

    Alejandro Padron, Shintaro Iwasaki, Nicholas Ingolia



    Selected by Christian Bates
    Close